Interview with Thorleif Møller, PhD
ThorleifMøller, PhD Mirrx Therapeutics A/S CEO & Founder How did you become interested in the field of oligonucleotides? During my PhD studies at the
OTS2022-09-24T05:00:36+00:00March 2nd, 2017|Categories: Featured Members|
ThorleifMøller, PhD Mirrx Therapeutics A/S CEO & Founder How did you become interested in the field of oligonucleotides? During my PhD studies at the
Oligonucleotide Therapeutics Society
3960 W Point Loma Blvd, Suite H
Box 346
San Diego, CA 92110
info@oligotherapeutics.org
© Copyright 2012 – 2024 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing